Antineutrophil cytoplasmic autoantibodies in patients with systemic sclerosis

British Journal of Dermatology

Volumn 134, Issue 3, 1996, Pages 407-410

  Akimoto, S ^a   Ishikawa, O ^a   Tamura, T ^a   Miyachi, Y ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

EID: 9044225526     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1996.tb16222.x     Document Type: Article

References (27)

1. Jennette JC, Falk RJ. Antineutrophil cytoplasmic autoantibodies and associated diseases: a review. Am J Kidney Dis 1990; 15: 517-29.
2. van der Woude FJ, Rasmussen N, Lobatto S et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985; i: 425-9.
3. Jennings JG, Chang L, Savige JA. Anti-proteinase 3 antibodies, their characterization and disease association. Clin Exp Immunol 1994; 95: 251-6.
4. Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988; 318: 1651-7.
5. Jennette JC, Wilkman AS, Falk RJ, Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol 1989; 135: 921-30.
6. Hauschild S, Schmitt WH, Csernok E et al. ANCA in systemic vasculitides, collagen vascular diseases, rheumatic disorders and inflammatory bowel diseases. Adv Exp Med Biol 1993; 336: 245-51.
7. Kallenberg CG, Mulder AHL, Tervaert JWC. Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. Am J Med 1992; 93: 675-82.
8. Croker BP, Tomlee, Gunnells JC. Clinical and pathologic features of polyarteritis nodosa and its renal-limited variant: primary crescentic and necrotizing glomerulonephritis. Hum Pathol 1987; 18: 38-44.
9. Tervaert JWC, Mulder L, Stegman C et al. Occurrence of auto-antibodies to human leucocyte elastase in Wegener's granulomatosis and other inflammatory disorders. Ann Rheum Dis 1993; 52: 115-20.
10. Coremans IEM, Hagen EC, Daha MR et al. Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. Arthritis Rheum 1992; 35: 1466-75.
11. Thomson RA, Lee SS. Antineutrophil cytoplasmic antibodies. Lancet 1989: i: 670-1.
12. Ishikawa O, Tamura T, Ohnishi K et al. Systemic sclerosis terminating as systemic necrotizing angiitis. Br J Dermatol 1993; 129: 736-8.
13. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
14. Barnett AJ. Scleroderma (progressive systemic sclerosis): progress and course based on personal series of 118 cases. Med J Aust 1978; 2: 129-54.
15. Black CM, Denton CP. The management of systemic sclerosis. Br J Rheumatol 1995; 34: 3-7.
16. Nassberger L, Sjoholm AG, Jonsson H, et al. Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus. Clin Exp Immunol 1990; 81: 380-3.
17. Pauzner R, Urowitz M, Gladman D et al. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. J Rheumatol 1994; 21: 1670-3.
18. Gross WL, Schmitt WH, Csernok E. Antineutrophil cytoplasmic autoantibody-associated diseases: a rheumatologist's perspective. Am J Kidney Dis 1991; 18: 175-9.
19. Endo H, Hosono T, Kondo H. Antineutrophil cytoplasmic auto-antibodies in 6 patients with renal failure and systemic sclerosis. J Rheumatol 1994; 21: 864-70.
20. Helrich DJ, Banner B, Steen VD et al. Normotensive renal failure in systemic sclerosis. Arthritis Rheum 1989; 32: 1128-54.
21. Masugi M, Ya S. Die diffuse sklerodermie und ihre Gefa veranderung. Virchows Arch 1938; 302: 39-62.
22. Ingram JT, Sutherland TW, Goldie W. Acrosclerosis and systemic sclerosis. Arch Dermatol 1958; 77: 79-85.
23. D'Angelo WA, Fries JF, Masi AT et al. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 1969; 46: 428-40.
24. Toth, A, Arpert LI. Progressive systemic sclerosis terminating as periarteritis nodosa. Arch Pathol 1971; 92: 31-6.
25. Tashiro Y, Hosoda Y, Yoshimura Y et al. A clinicopathological study on necrotizing vasculitis in progressive systemic sclerosis. Annual Report of the Ministry of Health and Welfare, Scleroderma Research Committee 1988; 111-14 (in Japanese).
26. Tervaert JWC, Brower E, Mulder AHL, et al. The detection of myeloperoxidase antibodies: a comparison of lour different techniques. Am J Kidney Dis 1991; 18: 198 (Abstr.).
27. Jane DRW, Jones SJ, Severn A et al. Severe pulmonary hemorrhage and systemic vasculitis in association with circulating antineutrophil cytoplasm antibodies of IgM class only. Clin Nephrol 1989; 32: 101-6.